Metraipolis › archive › dc_9edf64e012a2

Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis via MAPK signaling — Europe PMC PMID:42657110

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42657110
DOI
10.1515/jtim-2026-0061
License (as archived)
solo-consultazione
Archived
2026-10-19T06:55:53.693Z
SHA-256 of the archived text
424ff354fddf4506fc7c2759f2bed82746365677525f7aef7fe1db10ba809263
Stable URL of this page
https://metraipolis.com/documento/dc_9edf64e012a2

How to cite

Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis via MAPK signaling — Europe PMC PMID:42657110 — Europe PMC (en), https://europepmc.org/article/MED/42657110 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9edf64e012a2 (Metraipolis archive dc_9edf64e012a2, sha256 424ff354fddf4506fc7c2759f2bed82746365677525f7aef7fe1db10ba809263)
BibTeX
@misc{dc9edf64e012a2,
  title = {Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis via MAPK signaling — Europe PMC PMID:42657110},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42657110},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9edf64e012a2; sha256 424ff354fddf4506fc7c2759f2bed82746365677525f7aef7fe1db10ba809263},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42657110. Agents can read the archived copy with the MCP tool read_document.